Navigation Links
Hanger Orthopedic Group, Inc. Announces First Quarter 2011 Earnings Release Conference Call
Date:4/8/2011

AUSTIN, Texas, April 8, 2011 /PRNewswire/ -- Hanger Orthopedic Group, Inc. (NYSE: HGR) announced today that it plans to report its results of operations for the quarter ended March 31, 2011, on Thursday, April 28, 2011.

The Company plans to issue a press release announcing the results for the quarter ended March 31, 2011 on Wednesday, April 27, 2011 after the close of the market. A conference call to discuss these results is scheduled to begin at 9:00 a.m., EDT, on Thursday, April 28, 2011. Those wishing to participate should call 1-800-931-9710. In addition, a replay will be available until Thursday, May 5, 2011, by dialing 1-800-642-1687 and referencing Conference ID # 57315916.

About Hanger – Hanger Orthopedic Group, Inc., headquartered in Austin, Texas, is the world's premier provider for services and products that enhance human physical capability. Hanger provides orthotic and prosthetic patient care services, distributes O&P devices and components and provides therapeutic solutions to the broader post acute market.  Hanger is the largest owner and operator of orthotic and prosthetic patient care centers with in excess of 675 O&P patient care centers located in 45 states and the District of Columbia.  Hanger, through its subsidiary Southern Prosthetic Supply, Inc, is also the largest distributor of branded and private label O&P devices and components in the United States.  Hanger provides therapeutic solutions through its subsidiaries Innovative Neurotronics and Accelerated Care Plus.  Innovative Neurotronics introduces emerging neuromuscular technologies developed through independent research in a collaborative effort with industry suppliers worldwide.  Accelerated Care Plus is a developer of specialized rehabilitation technologies and the nation's leading provider of evidence-based clinical programs for post-acute
'/>"/>

SOURCE Hanger Orthopedic Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Hanger Orthopedic Group, Inc. Announces Fourth Quarter 2010 Earnings Release Conference Call
2. Hanger Orthopedic Group, Inc. Completes Exchange Offer of 7 1/8% Senior Notes Due 2018
3. Hanger Orthopedic Group, Inc. Announces Pricing of Underwritten Public Offering by Shareholder
4. Hanger Orthopedic Group, Inc. Announces Expiration of Offer to Purchase Outstanding 10 1/4% Senior Notes Due 2014
5. Hanger Orthopedic Group, Inc. Announces Early Tender Results of Offer to Purchase Outstanding 10-1/4% Senior Notes Due 2014
6. Hanger Orthopedic Group, Inc. Announces Pricing of $200 Million of Senior Notes
7. Hanger Orthopedic Group Signs Definitive Merger Agreement To Acquire Accelerated Care Plus
8. Hanger Orthopedic Group Announces Preliminary Third Quarter Revenue and Earnings
9. FDAs Just Approved Monthly Drug Treatment, Vivitrol Could Be Game Changer, Says Countrys Largest Drug Treatment Recovery President, CRCs Jerry Rhodes; Provides Addicts One Decision A Month Instead of 30
10. Hanger Orthopedic Group, Inc. Announces Third Quarter 2010 Earnings Release Conference Call
11. Hanger Orthopedic Group, Inc. Announces Second Quarter 2010 Earnings Release Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... -- Claret Medical, Inc. announced the publication of an original ... et al., Histopathology of Embolic Debris Captured During Transcatheter ... May 7 th this research is the result of ... Netherlands and the pathology team of Dr. ... Gaithersburg, Maryland.  This is the first time ...
(Date:5/18/2013)... , May 18, 2013 Faruqi ... firm, is investigating potential securities fraud at AVEO ... (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) ... and its executives violated federal securities laws by ... Company,s Phase III drug trials for Tivopath (tivozanib) ...
(Date:5/17/2013)... 17, 2013  Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... at the UBS Global Healthcare Conference in New ... 22 nd at 11 a.m. Eastern Time. To listen ... please visit the Investor Relations section of the Company,s Web ... for 14 days after the event. About Orexigen® ...
Breaking Medicine Technology:Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR 2Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2
... , CINCINNATI, Sept. 11 Kendle (Nasdaq: ... research organization, today announced that its regulatory affairs experts ... the Regulatory Affairs Professionals Society (RAPS) Annual Conference and ... Convention Center in Philadelphia. Demonstrating its leadership position in ...
... , , ... schedule of events at the Cardiovascular Research Foundation,s (CRF) annual ... 21st to Friday, September 25th, in San Francisco, CA. at ... world,s largest events for those performing cardiac diagnostics and interventions. ...
Cached Medicine Technology:Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition 2Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition 3InfraReDx to Showcase the LipiScan(TM) Coronary Imaging System at the Cardiovascular Research Foundation's (CRF) Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Meeting 2
(Date:5/20/2013)... May 20, 2013 This summer, digital ... world will make the pilgrimage to San Diego, CA, ... Digital Health Summer Summit produced by Living ... unique forum to showcase the latest digital health innovations, ... and network with some of industry’s most brilliant thinkers ...
(Date:5/20/2013)... 2013 Adeptia Inc., a ... business process integration solutions, today announced the ... integration solution. Version 6.0 is the ... automates business processes involving data access, validation, ... user interaction for real-time decision-making and exception-handling. ...
(Date:5/20/2013)... MONDAY, May 20 (HealthDay News) -- Although many ... physician on staff to help improve outcomes, new ... to patients. Since one-third of teaching hospitals ... in Europe staff a nighttime physician in the ... while siphoning doctors away from hospitals with fewer ...
(Date:5/20/2013)... In celebration of National Women’s Health ... achieved at The Feinstein Institute for Medical Research ... Advancing Women in Science and Medicine (AWSM) , hosted ... Scientists, educators, business and community leaders from the region ... women in science. , “Women face unique barriers ...
(Date:5/20/2013)... it about toothpaste that transforms the sweet flavor of ... to that mysterious sensory phenomenon in colorful, animated ... Chemical Society,s award-winning Bytesize Science video series ... world,s largest scientific society, explains that the mainstay ingredients ... or SLS for short. When you brush your teeth, ...
Breaking Medicine News(10 mins):Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 2Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 3Health News:Nighttime Docs at ICUs Don't Boost Patient Outcomes: Study 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3
... Childhood obesity can lead to type 2 diabetes, asthma, ... youth are likely to be obese as adults, experience ... incur higher healthcare costs. In an article published in ... of Preventive Medicine, researchers report that children living ...
... Oct. 27 HealthSouth,Corporation (NYSE: HLS ) today, ... is reaffirming its previously announced full year 2008,guidance and ... believes remain sound., In addition, HealthSouth noted the ... million in debt year to date,through October 27, 2008, ...
... Oct. 27 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) ... annual,BIO Investor Forum on Thursday, October 30, 2008 at ... in San Francisco, California., Steve Worland, Ph.D., President ... of Anadys and an update on its development,programs., ...
... Mich. To tackle the growing number of psychiatric cases in ... of Michigan State University doctors from the colleges of Osteopathic ... across the state via video conference. , On a ... up to 10 patients each from as far away as ...
... ANN ARBOR, Mich., Oct. 27 Parrish Medical ... implemented Clinical,Xpert CareFocus(TM) and Clinical Xpert Navigator which ... workflow solutions from the Healthcare business of,Thomson Reuters., ... patients,within a hospital and give clinicians access to ...
... even in combo, an effective long-term treatment , , MONDAY, ... methotrexate are safe and effective for long-term, continuous treatment ... In a three-year study that enrolled about 600 patients, ... methotrexate alone, others took etanercept alone, and another group ...
Cached Medicine News:Health News:Green neighborhoods may reduce childhood obesity 2Health News:HealthSouth Reaffirms Business Fundamentals and Full Year 2008 Guidance 2Health News:HealthSouth Reaffirms Business Fundamentals and Full Year 2008 Guidance 3Health News:Anadys Pharmaceuticals to Present at Bio Investor Forum 2Health News:MSU doctors bring much-needed psychiatric care to rural areas via technology 2Health News:Parrish Medical Center Deploys Clinical Xpert(TM) Solutions from Thomson Reuters 2Health News:Parrish Medical Center Deploys Clinical Xpert(TM) Solutions from Thomson Reuters 3Health News:Etanercept, Methotrexate Safe for Juvenile RA 2
Freer elevator, double end, 7 1/4", S/B....
... The Surgifoam* absorbable gelatin sponge, ... porcine gelatin absorbable sponge intended for ... bleeding surface. The sponge is off-white ... and speed to hemostasis, highly favorable ...
... The Surgifoam* absorbable gelatin sponge, ... porcine gelatin absorbable sponge intended for ... bleeding surface. The sponge is off-white ... and speed to hemostasis, highly favorable ...
16 mm diameter curved probes with suture eyes just back of blunt ends. Stainless steel. Round knurled handle with polished finish. Overall length: 5.7 inches....
Medicine Products: